Hosted on MSN1d
Brain-Computer Interfaces: Neuralink's Leap Forward
The boundary between science fiction and medical reality blurs as companies like Elon Musk's Neuralink make strides in ...
FiercePharma8h
AstraZeneca and Merck's Koselugo delivers phase 3 trial win in adults with NF1, teeing up filings
Four years after winning an FDA approval for Koselugo to treat children with the rare disorder neurofibromatosis type 1 (NF1) ...
STAT6d
These 6 companies are using AI to streamline clinical trials for pharma
Streamlining processes like trial site selection and FDA documentation can make a meaningful difference in development ...
AOL12d
FDA-approved drug for ulcerative colitis also effective for Crohn's
Mirikizumab is a drug currently approved by the Food ... study participants who achieved clinical remission with mirikizumab at 1 year in the LUCENT-2 clinical trial, researchers found after ...
Business Wire7d
Cancer Antibody Drug Conjugates Market, Drugs Approval, Price, Sales & Clinical Trials Insight to 2030 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030" report has been added to ResearchAndMarkets.com's offering.
Journey Medical announces U.S. FDA approval of Emrosi
Journey Medical (DERM) announced that the FDA has approved Emrosi, formerly referred to as DFD-29, for the treatment of inflammatory lesions of ...
manilatimes12d
Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing Device
"Receiving FDA approval to initiate this pivotal study marks a significant ... and beginning of Envoy Medical's clinical trial, the timing of and FDA's position related to expanding the clinical trial ...
MarketWatch4d
Autolus Therapeutics Gets FDA Approval for Cancer Treatment
Autolus Therapeutics said it received Food and Drug ... Its approval was based on the results of a clinical study in which 42% of patients with the cancer achieved complete remission within three ...
manilatimes12d
The Phase III clinical trial application for first-line treatment of extensive disease small cell lung cancer with Chiauranib has been approved
The company's self-developed original new drug, Chiauranib, combined with PD - (L) 1 monoclonal antibody and standard chemotherapy for the first-line treatment of extensive stage small cell lung ...
The Star9d
Musk's Neuralink to start human trial of brain implant for paralysis patients
(Reuters) -Billionaire entrepreneur Elon Musk's brain-chip startup Neuralink said on ... had received clearance from the FDA for its first-in-human clinical trial, when it was already under ...
NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy
The RNS System Post-Approval Study (PAS) is the largest prospective post-approval study in neuromodulation for patients with drug-resistant focal ...
Morningstar12d
The Phase III clinical trial application for first-line treatment of extensive disease small cell lung cancer with Chiauranib has been approved
The company's self-developed original new drug, Chiauranib ... stage small cell lung cancer, has been approved for phase III clinical trials. Extensive disease small cell lung cancer (ES-SCLC ...